• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday

    11/23/22 5:25:59 AM ET
    $A
    $AEO
    $AGBA
    $ANF
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary
    Get the next $A alert in real time by email

    Gainers

    • Cosmos Holdings Inc. (NASDAQ:COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on Iberian Airlines' in-flight magazine, Ronda.
    • Palisade Bio, Inc. (NASDAQ:PALI) shares climbed 81.1% to close at $4.02 on Tuesday after the company announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return of bowel function following surgery.
    • Motorsport Games Inc. (NASDAQ:MSGM) gained 51.1% to settle at $6.80. The company recently posted downbeat quarterly results.
    • FOXO Technologies Inc. (NYSE:FOXO) surged 47.6% to close at $0.72. Foxo Technologies, said effective November 14, 2022, Jon Sabes has been terminated as CEO and Chairman of board of company.
    • Grindr Inc. (NYSE:GRND) fell 37.9% to close at $12.25 on Tuesday after dropping 46% on Monday.
    • Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) jumped 34.3% to close at $0.7524. Cyclerion said it concluded the unsolicited proposal received on November 20 was “not in the best interest of the company.”
    • Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) gained 30% to close at $1.95. The company recently posted downbeat quarterly earnings.
    • Digital Brands Group, Inc. (NASDAQ:DBGI) gained 28.5% to close at $4.28. Digital Brands Group recently posted Q3 sales of $3.40 million.
    • Draganfly Inc. (NASDAQ:DPRO) jumped 27.2% to close at $1.17. Draganfly has been selected by PromoDrone to provide its Public Safety technology to the PromoDrone platform for Emergency Management.
    • GH Research PLC (NASDAQ:GHRS) gained 25.9% to settle at $12.51. GH Research recently posted a Q3 net loss of $0.008 per share.
    • Cingulate Inc. (NASDAQ:CING) climbed 25.7% to close at $0.87. Maxim Group initiated coverage on Cingulate with a Buy rating and announced a price target of $3.
    • Abercrombie & Fitch Co. (NYSE:ANF) climbed 21.4% to close at $22.62 after the company reported better-than-expected Q3 EPS and sales results.
    • Burlington Stores, Inc. (NYSE:BURL) surged 20.5% to close at $189.96 after the company reported Q3 financial results and issued guidance.
    • Polestar Automotive Holding UK PLC (NASDAQ:PSNY) gained 20.5% to settle at $7.82.
    • Sangoma Technologies Corporation (NASDAQ:SANG) rose 19.2% to settle at $4.72.
    • Starbox Group Holdings Ltd. (NASDAQ:STBX) gained 18.6% to settle at $2.49.
    • Bonso Electronics International Inc. (NASDAQ:BNSO) shares gained 18.5% to close at $3.68.
    • American Eagle Outfitters, Inc. (NYSE:AEO) gained 18.2% to close at $15.36 after the company reported better-than-expected Q3 GAAP EPS and sales results.
    • Bon Natural Life Limited (NASDAQ:BON) jumped 16.7% to close at $1.12.
    • COMSovereign Holding Corp. (NASDAQ:COMS) rose 16.6% to close at $0.0675.
    • WW International, Inc. (NASDAQ:WW) climbed 16.5% to close at $4.23. Sima Sistani, Chief Executive Officer at WW International, reported a large insider buy on November 21, according to a new SEC filing.
    • ObsEva SA (NASDAQ:OBSV) shares jumped 16.5% to close at $0.1931 after the company reported the sale of Ebopiprant license agreement to XOMA for up to $113 million.
    • Maximus, Inc. (NYSE:MMS) gained 16.2% to close at $70.34 after the company reported better-than-expected Q4 EPS and sales results. The company also issued FY23 EPS and sales guidance above analyst estimates.
    • Charah Solutions, Inc. (NYSE:CHRA) gained 16.2% to close at $1.02. Charah Solutions recently reported mixed Q3 results.
    • CN Energy Group. Inc. (NASDAQ:CNEY) jumped 16.2% to close at $1.79.
    • TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) climbed 16.1% to close at $1.44. TFF Pharmaceuticals recently priced a $10.675 million offering of common stock and warrants.
    • NextNav Inc. (NASDAQ:NN) gained 15.8% to close at $3.6250.
    • Mirati Therapeutics, Inc. (NASDAQ:MRTX) surged 15.5% to close at $86.11. Mirati Therapeutics is said to draw fresh takeover interest.
    • Warner Music Group Corp. (NASDAQ:WMG) gained 15.2% to close at $31.09. Warner Music Group reported fourth-quarter FY22 revenue growth of 8.8% year-on-year to $1.497 billion, beating the consensus of $1.42 billion.
    • Manchester United plc (NYSE:MANU) gained 14.7% to close at $14.94. The company recently posted upbeat quarterly earnings.
    • Provention Bio, Inc. (NASDAQ:PRVB) gained 14.4% to close at $8.89. The FDA recently approved Provention Bio’s Tzield (teplizumab-mzwv) injection to delay the onset of stage 3 type 1 diabetes in adults and pediatric patients eight years and older who currently have stage 2 type 1 diabetes.
    • Biodesix, Inc. (NASDAQ:BDSX) gained 13.9% to close at $1.48. Biodesix 10% owner Jack Schuler acquired a total of 8,695,652 shares at an average price of $1.15.
    • Best Buy Co., Inc. (NYSE:BBY) rose 12.8% to close at $79.88 after the company reported better-than-expected Q3 EPS and sales results.
    • 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) gained 12.6% to close at $23.50.
    • Dyne Therapeutics, Inc. (NYSE:DYN) gained 9.9% to close at $10.30.
    • Nexalin Technology, Inc. (NASDAQ:NXL) climbed 9.3% to close at $2.24 after surging around 14% on Monday.
    • Harsco Corporation (NYSE:HSC) gained 8.9% to settle at $7.19.
    • Urban Outfitters, Inc. (NASDAQ:URBN) rose 8.9% to close at $27.80 after the company reported better-than-expected Q3 sales.
    • Agilent Technologies, Inc. (NYSE:A) climbed 8.1% to close at $156.86 after the company reported better-than-expected Q4 EPS and sales results.
    • Big Lots, Inc. (NYSE:BIG) gained 7.7% to close at $19.20.
    • Angel Pond Holdings Corporation (NYSE:POND) gained 5.6% to close at $10.30.

     


    Losers

    • Perfect Corp. (NYSE:PERF) dropped 39.2% to close at $5.27 on Tuesday. Goldman Sachs, on Monday, initiated coverage on Perfect with a Neutral rating and announced a price target of $7.8.
    • Grindr Inc. (NYSE:GRND) fell 37.9% to close at $12.25.
    • Phoenix New Media Limited (NYSE:FENG) fell 36.6% to close at $2.81.
    • Eqonex Limited (NASDAQ:EQOS) dipped 32.8% to close at $0.1411 on Tuesday after dipping around 24% on Monday.
    • WiSA Technologies, Inc. (NASDAQ:WISA) fell 23.9% to close at $0.1965.
    • Quotient Limited (NASDAQ:QTNT) dropped 22.5% to settle at $0.86.
    • AGBA Group Holding Limited (NASDAQ:AGBA) fell 21.4% to close at $4.9650. AGBA Acquisition Limited recently completed its business combination with TAG Holdings Limited.
    • Graybug Vision, Inc. (NASDAQ:GRAY) dropped 21.2% to close at $0.7450. Graybug Vision and CalciMedica have announced a definitive merger agreement to combine the companies in an all-stock transaction.
    • WaveDancer, Inc. (NASDAQ:WAVD) fell 21.1% to close at $0.5715. WaveDancer posted Q3 sales of $2.30 million.
    • Atento S.A. (NYSE:ATTO) dipped 21% to settle at $5.53.
    • Brooge Energy Limited (NASDAQ:BROG) fell 20.2% to close at $5.65.
    • VIQ Solutions Inc. (NASDAQ:VQS) fell 20% to close at $0.2480.
    • Agora, Inc. (NASDAQ:API) fell 20% to close at $2.68 after the company posted downbeat Q3 results and issued weak FY22 sales forecast.
    • Core Scientific, Inc. (NASDAQ:CORZ) dipped 20% to settle at $0.1342.
    • Conformis, Inc. (NASDAQ:CFMS) dropped 19.9% to settle at $1.93.
    • Satixfy Communications Ltd. (NYSE:SATX) dropped 19.6% to close at $25.04.
    • Scopus BioPharma Inc. (NASDAQ:SCPS) fell 18.2% to close at $0.2001.
    • Top Ships Inc. (NASDAQ:TOPS) dropped 18.1% to close at $2.35.
    • Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) fell 17.8% to close at $2.03.
    • Dycom Industries, Inc. (NYSE:DY) fell 17.7% to close at $90.20 after the company reported Q3 earnings results.
    • Noah Holdings Limited (NYSE:NOAH) dropped 17.1% to settle at $12.41 following Q3 results.
    • Construction Partners, Inc. (NASDAQ:ROAD) fell 16.1% to close at $27.29 after reporting Q4 results.
    • Jack in the Box Inc. (NASDAQ:JACK) fell 16.1% to close at $71.24 after the company issued soft FY23 guidance.
    • EUDA Health Holdings Limited (NASDAQ:EUDA) fell 15.9% to close at $3.18 after dipping 15% on Monday.
    • iQIYI, Inc. (NASDAQ:IQ) fell 14.4% to close at $2.43 following Q3 results.
    • FiscalNote Holdings, Inc. (NASDAQ:NOTE) dipped 13.9% to close at $5.14
    • GDS Holdings Limited (NASDAQ:GDS) fell 13.7% to close at $11.93.
    • Actinium Pharmaceuticals, Inc. (NYSE:ATNM) declined 13.1% to close at $10.24.
    • Gamida Cell Ltd. (NASDAQ:GMDA) fell 12.9% to close at $1.55 after the company issued a regulatory update on Omidubicel. The company said it received extension of Omidubicel PDUFA Date from Jan. 30, 2023 to May 1, 2023 as the FDA issued information request.
    • Movado Group, Inc. (NYSE:MOV) fell 10.1% to close at $30.11 after the company posted downbeat quarterly sales and lowered FY23 sales forecast.
    • Chico's FAS, Inc. (NYSE:CHS) dipped 10% to settle at $6.40 after the company issued weak Q4 forecast.
    • Canoo Inc. (NASDAQ:GOEV) fell 9.1% to close at $1.0550. The company recently posted a narrower-than-expected quarterly loss.
    • Nikola Corporation (NASDAQ:NKLA) dropped 9.1% to settle at $2.30
    • Central Garden & Pet Company (NASDAQ:CENTA) fell 8.8% to close at $38.24 following weak quarterly results.
    • Dollar Tree, Inc. (NASDAQ:DLTR) fell 7.8% to close at $152.37 after the company reported Q3 earnings results.
    • Mesa Laboratories, Inc. (NASDAQ:MLAB) declined 7.7% to close at $169.90 after the company announced its Clinical Genomics Division customer, Sema4, will exit the reproductive health screening business. Sema4 informed the company it will reduce the quantity of orders in Q3.
    • Zoom Video Communications, Inc. (NASDAQ:ZM) slipped 3.9% to close at $77.15 after the company reported better-than-expected results, but issued weak guidance.
    Get the next $A alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $A
    $AEO
    $AGBA
    $ANF

    CompanyDatePrice TargetRatingAnalyst
    NextNav Inc.
    $NN
    4/16/2026$25.00Perform → Outperform
    Oppenheimer
    Best Buy Co. Inc.
    $BBY
    4/13/2026$59.00Buy → Sell
    Goldman
    Palisade Bio Inc.
    $PALI
    4/9/2026$7.00Outperform
    Wolfe Research
    Construction Partners Inc.
    $ROAD
    4/3/2026$135.00Neutral → Buy
    B. Riley Securities
    Construction Partners Inc.
    $ROAD
    4/2/2026$135.00Neutral → Buy
    B. Riley Securities
    Palisade Bio Inc.
    $PALI
    3/26/2026$7.00Buy
    H.C. Wainwright
    American Eagle Outfitters Inc.
    $AEO
    3/26/2026Hold
    Needham
    Abercrombie & Fitch Company
    $ANF
    3/26/2026$108.00Buy
    Needham
    More analyst ratings

    $A
    $AEO
    $AGBA
    $ANF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by President and CEO Kadia Siddhartha

    4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    4/24/26 10:49:12 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    SEC Form 3 filed by new insider Kadia Siddhartha

    3 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    4/24/26 10:41:18 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Chief Commercial Officer Dicken Scott Fraser converted options into 1,764 units of Class A American Depositary Shares and was granted 92 units of Class A American Depositary Shares (SEC Form 4)

    4 - Polestar Automotive Holding UK PLC (0001884082) (Issuer)

    4/23/26 5:17:02 PM ET
    $PSNY
    Auto Manufacturing
    Industrials

    $A
    $AEO
    $AGBA
    $ANF
    SEC Filings

    View All

    Motorsport Games Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Other Events

    8-K - Motorsport Games Inc. (0001821175) (Filer)

    4/24/26 4:48:27 PM ET
    $MSGM
    Computer Software: Prepackaged Software
    Technology

    SEC Form 144 filed by Dyne Therapeutics Inc.

    144 - Dyne Therapeutics, Inc. (0001818794) (Subject)

    4/24/26 4:47:05 PM ET
    $DYN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 144 filed by Dyne Therapeutics Inc.

    144 - Dyne Therapeutics, Inc. (0001818794) (Subject)

    4/24/26 4:46:22 PM ET
    $DYN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $A
    $AEO
    $AGBA
    $ANF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    NextNav upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded NextNav from Perform to Outperform and set a new price target of $25.00

    4/16/26 7:59:04 AM ET
    $NN
    Industrial Machinery/Components
    Industrials

    Best Buy downgraded by Goldman with a new price target

    Goldman downgraded Best Buy from Buy to Sell and set a new price target of $59.00

    4/13/26 8:42:52 AM ET
    $BBY
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Wolfe Research initiated coverage on Palisade Bio with a new price target

    Wolfe Research initiated coverage of Palisade Bio with a rating of Outperform and set a new price target of $7.00

    4/9/26 8:43:44 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $A
    $AEO
    $AGBA
    $ANF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Posner Brian S bought $38,700 worth of shares (2,000 units at $19.35), increasing direct ownership by 17% to 13,500 units (SEC Form 4)

    4 - Dyne Therapeutics, Inc. (0001818794) (Issuer)

    3/13/26 4:46:19 PM ET
    $DYN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Ladiwala Shiraz Shabanali bought $252,805 worth of shares (3,500 units at $72.23), increasing direct ownership by 70% to 8,523 units (SEC Form 4)

    4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    3/10/26 5:43:24 PM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    Director Posner Brian S bought $45,180 worth of shares (3,000 units at $15.06), increasing direct ownership by 35% to 11,500 units (SEC Form 4)

    4 - Dyne Therapeutics, Inc. (0001818794) (Issuer)

    3/10/26 5:33:53 PM ET
    $DYN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $A
    $AEO
    $AGBA
    $ANF
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for TZIELD issued to PROVENTION BIO INC

    Submission status for PROVENTION BIO INC's drug TZIELD (SUPPL-13) with active ingredient TEPLIZUMAB-MZWV has changed to 'Approval' on 04/20/2026. Application Category: BLA, Application Number: 761183, Application Classification:

    4/23/26 6:14:48 PM ET
    $PRVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    June 18, 2024 - FDA Roundup: June 18, 2024

    For Immediate Release: June 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a request for input about patient safety associated with certain medical software functions excluded from the medical device definition. This input will help the FDA develop the 2024 report on the risks and benefits to health of non-devic

    6/18/24 3:16:28 PM ET
    $DLTR
    $AMGN
    Department/Specialty Retail Stores
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    April 17, 2023 - FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation

    For Immediate Release: April 17, 2023 Today, the U.S. Food and Drug Administration approved Omisirge (omidubicel-onlv), a substantially modified allogeneic (donor) cord blood-based cell therapy to quicken the recovery of neutrophils (a subset of white blood cells) in the body and reduce the risk of infection. The product is intended for use in adults and pediatric patients 12 years and older with blood cancers p

    4/17/23 1:02:15 PM ET
    $GMDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $A
    $AEO
    $AGBA
    $ANF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Core Scientific, Inc. Schedules First Quarter Fiscal Year 2026 Earnings Release, Conference Call and Webcast

    Core Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or the "Company"), a leader in digital infrastructure for high-density colocation ("HDC"), today announced it will release its first quarter 2026 financial results after the financial markets close on Wednesday, May 6, 2026. Management will host a conference call and live audio webcast to discuss the results at 3:30 p.m. Central Time. Hosting the call and webcast to review results for the first quarter 2026 will be Adam Sullivan, Chief Executive Officer, Matt Brown, Chief Operating Officer, Jim Nygaard, Chief Financial Officer, and Jon Charbonneau, Vice President, Investor Relations. Conference Call and Webcast Event Summary Date:

    4/24/26 4:30:00 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Buy Research Opinion on Zoom Communications (NASDAQ: ZM)

    NOTE TO EDITORS: The Following Is an Investment Opinion Issued by Spruce Point Capital Management Provides Evidence the Bear Thesis on Zoom Shares Does Not Hold Up to Scrutiny Believes Zoom's Transformation Into a Comprehensive, Value-Added, AI-First Platform Poised to Drive Deeper Enterprise Penetration is Underappreciated Demonstrates Zoom is Trading at a Massive Discount to Its Intrinsic Value, Particularly Considering Its Share Ownership in AI Leader Anthropic Identifies A Range of Cost Structure, Organizational Effectiveness, Capital Allocation Practices, and Corporate Governance Concerns For Zoom to Address Announces It Has Sent the Zoom Board of Directors a Letter Containin

    4/24/26 8:30:00 AM ET
    $ZM
    Computer Software: Programming Data Processing
    Technology

    iQIYI Returns to LVL UP EXPO 2026 in Las Vegas with Blacklyte, Debuting Peter Pau AI Theater and Immersive AI Experiences

    LAS VEGAS, April 24, 2026 /PRNewswire/ -- iQIYI International showcases AI-powered storytelling, Chinese anime, and VIP giveaways at the Las Vegas Convention Center on April 24–26, 2026, in partnership with premium Canadian immersive ecosystem brand, Blacklyte. Founded in 2010, iQIYI (NASDAQ:IQ) is one of Asia's largest online entertainment platforms, and iQIYI International, launched in 2019, now serves over 100 million users across 190+ territories with a user interface and subtitles in 13 languages.Experience the Future of AI StorytellingAt this year's LVL UP EXPO, iQIYI debu

    4/24/26 8:00:00 AM ET
    $IQ
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $A
    $AEO
    $AGBA
    $ANF
    Leadership Updates

    Live Leadership Updates

    View All

    Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors

    NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company"), the global leader in science-backed weight management, today announced that it has appointed Heather Thiltgen to the Company's Board of Directors, effective April 20, 2026. Ms. Thiltgen currently serves as the President of Presbyterian Health Plan and previously served as President & CEO of WellSense Health Plan. As Weight Watchers expands its integrated weight health platform, Ms. Thiltgen brings decades of successful healthcare leadership experience with expertise in: Expanding coverage and access to GLP-1 therapies;Navigating complex regulatory environments, including

    4/20/26 7:30:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Zoom appoints Russell Dicker as chief product officer to advance AI-first product strategy and workflow automation

    SAN JOSE, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- Zoom Communications, Inc. (NASDAQ:ZM) today announced the appointment of Russell Dicker as the company's chief product officer (CPO), leading product strategy for Zoom's system of action, turning conversations into completed work through AI. Russell brings more than 25 years of experience building and scaling global product platforms, including leading Microsoft Teams' product and data science teams, with a focus on applying AI to simplify workflows and improve how work gets done. Russell joins Zoom at a pivotal time, as companies seek AI tools to automate processes and tasks, freeing up time for higher-level work. Zoom is uniquely posi

    4/15/26 9:05:00 AM ET
    $ZM
    Computer Software: Programming Data Processing
    Technology

    Agilent Showcases Cancer Research Solutions at AACR 2026

    Agilent Technologies Inc. (NYSE:A) will present new technologies, scientific collaborations, and integrated workflows supporting cancer research and diagnostics at the American Association for Cancer Research (AACR) Annual Meeting on April 17–22, 2026, in San Diego, California. At the meeting, Agilent will highlight advances designed to connect discovery research, translational science, and companion diagnostics development, reflecting the growing demand for more integrated approaches across the cancer research continuum. Among the technologies featured is the BioTek Cytation 9 cell imaging multimode reader, the newest addition to the Cytation series of cell imaging and multimode micropla

    4/15/26 8:00:00 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $A
    $AEO
    $AGBA
    $ANF
    Financials

    Live finance-specific insights

    View All

    Core Scientific, Inc. Schedules First Quarter Fiscal Year 2026 Earnings Release, Conference Call and Webcast

    Core Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or the "Company"), a leader in digital infrastructure for high-density colocation ("HDC"), today announced it will release its first quarter 2026 financial results after the financial markets close on Wednesday, May 6, 2026. Management will host a conference call and live audio webcast to discuss the results at 3:30 p.m. Central Time. Hosting the call and webcast to review results for the first quarter 2026 will be Adam Sullivan, Chief Executive Officer, Matt Brown, Chief Operating Officer, Jim Nygaard, Chief Financial Officer, and Jon Charbonneau, Vice President, Investor Relations. Conference Call and Webcast Event Summary Date:

    4/24/26 4:30:00 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Buy Research Opinion on Zoom Communications (NASDAQ: ZM)

    NOTE TO EDITORS: The Following Is an Investment Opinion Issued by Spruce Point Capital Management Provides Evidence the Bear Thesis on Zoom Shares Does Not Hold Up to Scrutiny Believes Zoom's Transformation Into a Comprehensive, Value-Added, AI-First Platform Poised to Drive Deeper Enterprise Penetration is Underappreciated Demonstrates Zoom is Trading at a Massive Discount to Its Intrinsic Value, Particularly Considering Its Share Ownership in AI Leader Anthropic Identifies A Range of Cost Structure, Organizational Effectiveness, Capital Allocation Practices, and Corporate Governance Concerns For Zoom to Address Announces It Has Sent the Zoom Board of Directors a Letter Containin

    4/24/26 8:30:00 AM ET
    $ZM
    Computer Software: Programming Data Processing
    Technology

    Weight Watchers Schedules First Quarter 2026 Earnings Conference Call

    NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company") will release its results for the first quarter 2026 ended March 31, 2026, before market open on Thursday, May 7, 2026. Weight Watchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. About Weight WatchersWeight Watchers is the global leader in science-backed weight management, offering an integrated support system built for the GLP-

    4/23/26 4:01:00 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $A
    $AEO
    $AGBA
    $ANF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by NextNav Inc.

    SC 13D/A - NEXTNAV INC. (0001865631) (Subject)

    12/6/24 6:03:25 PM ET
    $NN
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13D/A filed by iQIYI Inc.

    SC 13D/A - iQIYI, Inc. (0001722608) (Subject)

    12/4/24 8:11:53 AM ET
    $IQ
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by TFF Pharmaceuticals Inc.

    SC 13G/A - TFF Pharmaceuticals, Inc. (0001733413) (Subject)

    11/19/24 4:05:58 PM ET
    $TFFP
    Biotechnology: Pharmaceutical Preparations
    Health Care